ArticleJournal of virology2026
Chicken infectious anemia virus exploits host CK2α as an essential factor for its replication via VP2 Ser182/Asp183-mediated interaction.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chicken infectious anemia virus (CIAV) induces severe immunosuppression in chickens. The nonstructural protein VP2 of CIAV is shown to play critical roles in viral assembly and viral replication. However, the molecular mechanisms by which CIAV VP2 hijacks host machinery to promote efficient viral replication remain elusive. Here, we showed that casein kinase 2 alpha (CK2α) subunit was identified to interact with CIAV VP2 to promote viral replication. We found that knockdown of cellular CK2α by RNAi in MDCC-MSB1 or inhibition of its kinase activity by an inhibitor significantly suppressed CIAV replication in cells. Furthermore, we verified that CK2α stabilized VP2 by inhibiting its proteasomal degradation. In addition, we demonstrated that Ser182 and Asp183 of VP2 served as essential residues for CK2α binding. Using reverse genetics technique, we rescued the recombinant virus with mutations at Ser182 and Asp183 of VP2 and demonstrated that mutations at these sites disrupted VP2-CK2α binding, reduced viral replication, and mitigated CIAV-induced bone marrow hypoplasia and thymic damage IMPORTANCE: Chicken infectious anemia virus (CIAV) causes severe immunosuppression and substantial economic losses in the global poultry industry. Current strategies to control CIAV infection are still limited. This study identifies host kinase casein kinase 2 alpha (CK2α) as a key cellular factor that binds and stabilizes CIAV VP2, promoting viral replication. Inhibition or knockdown of CK2α suppressed viral replication. The rescued virus with VP2 S182A/D183A mutations exhibited reduced viral replication and attenuated pathogenicity. These findings reveal a crucial mechanism whereby CIAV VP2 exploits host CK2α for efficient viral replication, highlighting the VP2-CK2α interaction as a potential target for developing novel antiviral strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.